December 1, 2020

The Niche

Knoepfler lab stem cell blog

Results of FDA Reform Poll: speed up clinical trials & expand compassionate use

FDA poll stem cellsThe poll I put up asking people their #1 top priority for FDA reform drew relatively big numbers of respondents.

Speeding up clinical trials was clearly way out in front at #1.

Expanding compassionate use was #2.

These were followed by changing policy to no longer define lab-grown stem cells as drugs and FDA being more proactive against non-compliant clinics.